<?xml version="1.0" encoding="UTF-8"?>
<ref id="B61-viruses-11-00912">
 <label>61.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fantini</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Hammache</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Delézay</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Yahi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>André-Barrès</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Rico-Lattes</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Lattes</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry</article-title>
  <source>J. Biol. Chem.</source>
  <year>1997</year>
  <volume>272</volume>
  <fpage>7245</fpage>
  <lpage>7252</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.272.11.7245</pub-id>
  <?supplied-pmid 9054420?>
  <pub-id pub-id-type="pmid">9054420</pub-id>
 </element-citation>
</ref>
